Claims for Patent: 6,042,825

Summary for Patent: 6,042,825

Title:	Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
Abstract:	The present invention relates to: parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules, including those that encode such asparaginase proteins; antibodies raised against such asparaginase proteins; and compounds that inhibit parasitic helminth asparaginase activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths.
Inventor(s):	Chandrashekar; Ramaswamy (Fort Collins, CO), Tsuji; Naotoshi (Fort Collins, CO)
Assignee:	Heska Corporation (Fort Collins, CO) Colorado State Universty Research Foundation (Fort Collins, CO)
Application Number:	09/140,177
Patent Claims:	1. An isolated Dirofilaria immitis asparaginase protein. 2. The asparaginase of claim 1, wherein said protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:7, and SEQ ID NO:12. 3. The asparaginase protein of claim 1, wherein said protein is encoded by a nucleic acid molecule selected from the group consisting a nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:9, SEQ ID NO:11 and SEQ ID NO:25, and an allelic variant of any of said nucleic acid sequence. 4. The asparaginase protein of claim 1, wherein said protein, when administered to an animal, elicits an immune response against a Dirofilaria immitis asparaginase protein. 5. A therapeutic composition to protect an animal from disease, said therapeutic composition comprising ani isolated Dirofilaria immitis asparaginase protein. 6. The composition of claim 5, wherein said composition further comprises a component selected from the group consisting of an adjuvant, an excipient and a carrier. 7. A method to protect an animal from disease, said method comprising administering to said animal a therapeutic composition comprising an isolated Dirofilaria immitis asparaginase protein. 8. The method of claim 7, wherein said composition further comprises a component selected from the group consisting of an excipient, an adjuvant, and a carrier. 9. A method to identify a compound capable of inhibiting Dirofilaria immitis asparaginase activity, said method comprising: (a) contacting an isolated Dirofilaria immitis asparaginase protein with a putative inhibitory compound under conditions in which, in the absence of said compound, said protein has asparaginase activity; and (b) determining the inhibition of asparaginase activity by the said compound. 10. A test kit to identify a compound capable of inhibiting Dirofilaria immitis asparaginase activity, said test kit comprising an isolated Dirofilaria immitis asparaginase protein, said protein having asparaginase activity.

Details for Patent 6,042,825

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2017-09-15